- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00593359
Intraocular Pressure During Spine Surgery
The Effect of Lactated Ringer's Solution Versus Albumin and the Alpha-2 Agonist Brimonidine Versus Placebo on Intraocular Pressure During Prone Spine Surgery
This study will compare the effect of two intravenous solutions on eye pressure during spine surgery in the following groups:
Group A - Lactated Ringer's replacement for blood loss and placebo eye drops
Group B - Lactated Ringer's replacement for blood loss and brimonidine eye drops
Group C - Albumin replacement for blood loss and placebo eye drops
Group D - Albumin replacement for blood loss and brimonidine eye drops
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Spine surgery with instrumentation in prone position expected to last at least 5 hours;
- Anticipated blood loss ≥ 1L
- Age 18-80 years old;
- ASA physical status I-III.
Exclusion Criteria:
- History of increased intraocular pressure or glaucoma;
- Diabetic retinopathy;
- Heart failure or serious left ventricular dysfunction;
- Abnormal preoperative fundus examination;
- Creatinine > 2 mg/dL;
- Patient refuses blood transfusion or albumin administration
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
A
Lactated Ringer's replacement for blood loss and placebo eye drops
|
|
B
Lactated Ringer's replacement for blood loss and brimonidine eye drops
|
|
C
Albumin replacement for blood loss and placebo eye drops;
|
|
D
Albumin replacement for blood loss and brimonidine eye drops
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The primary outcome will be the maximum intraocular pressure at any time during surgery.
Time Frame: 15 days post surgery
|
15 days post surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Intraocular pressure as a function of surgical duration; Velocity of retrobulbar blood flow; Facial edema and or chemosis; Time to extubation; Duration of recovery Correlation between Dpp and FTc.
Time Frame: 15 days post surgery
|
15 days post surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 07-571
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.